Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerhard Rogler

Showing results (531-540 of 547) with videos related to

Pageof 55
Sort By:
Journal of Pediatric Gastroenterology and Nutrition|November 2, 2016
Extraintestinal Manifestations of Pediatric Inflammatory Bowel Disease: Prevalence, Presentation, and Anti-TNF TreatmentThomas Greuter, Fabio Bertoldo, Roman Rechner, et al.
Clinical and Translational Gastroenterology|July 29, 2022
Magnetic Resonance Enterography and Histology in Patients With Fibrostenotic Crohn's Disease: A Multicenter StudyAlexandre Coimbra, Jordi Rimola, Miriam Cuatrecasas, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 19, 2020
Dietary Guidance From the International Organization for the Study of Inflammatory Bowel DiseasesArie Levine, Jonathan M Rhodes, James O Lindsay, et al.
Gut Microbes|July 21, 2025
Blood-borne immune cells carry low biomass DNA remnants of microbes in patients with colorectal cancer or inflammatory bowel diseaseYasser Morsy, Åsa Walberg, Paulina Wawrzyniak, et al.
JAMA|December 17, 2015
Autologous Hematopoetic Stem Cell Transplantation for Refractory Crohn Disease: A Randomized Clinical TrialChristopher J Hawkey, Matthieu Allez, Miranda M Clark, et al.
Kidney International|July 15, 2019
Tumor necrosis factor stimulates fibroblast growth factor 23 levels in chronic kidney disease and non-renal inflammationDaniela Egli-Spichtig, Pedro Henrique Imenez Silva, Bob Glaudemans, et al.
Lancet (London, England)|June 6, 2021
Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trialBrian G Feagan, Silvio Danese, Edward V Loftus, et al.
Nature Reviews. Gastroenterology & Hepatology|June 3, 2024
A global consensus on the definitions, diagnosis and management of fibrostenosing small bowel Crohn's disease in clinical practiceDominik Bettenworth, Mark E Baker, Joel G Fletcher, et al.
International Journal of Cancer|January 18, 2019
β<sub>6</sub> -integrin serves as a novel serum tumor marker for colorectal carcinomaSusan Bengs, Eugenia Becker, Philipp Busenhart, et al.
Cell Host & Microbe|August 28, 2021
Commensal Clostridiales strains mediate effective anti-cancer immune response against solid tumorsAna Montalban-Arques, Egle Katkeviciute, Philipp Busenhart, et al.
Pageof 55

Showing results (531-540 of 547) with videos related to

Sort By:
Pageof 55
Journal of Pediatric Gastroenterology and Nutrition|November 2, 2016
Extraintestinal Manifestations of Pediatric Inflammatory Bowel Disease: Prevalence, Presentation, and Anti-TNF TreatmentThomas Greuter, Fabio Bertoldo, Roman Rechner, et al.
Clinical and Translational Gastroenterology|July 29, 2022
Magnetic Resonance Enterography and Histology in Patients With Fibrostenotic Crohn's Disease: A Multicenter StudyAlexandre Coimbra, Jordi Rimola, Miriam Cuatrecasas, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 19, 2020
Dietary Guidance From the International Organization for the Study of Inflammatory Bowel DiseasesArie Levine, Jonathan M Rhodes, James O Lindsay, et al.
Gut Microbes|July 21, 2025
Blood-borne immune cells carry low biomass DNA remnants of microbes in patients with colorectal cancer or inflammatory bowel diseaseYasser Morsy, Åsa Walberg, Paulina Wawrzyniak, et al.
JAMA|December 17, 2015
Autologous Hematopoetic Stem Cell Transplantation for Refractory Crohn Disease: A Randomized Clinical TrialChristopher J Hawkey, Matthieu Allez, Miranda M Clark, et al.
Kidney International|July 15, 2019
Tumor necrosis factor stimulates fibroblast growth factor 23 levels in chronic kidney disease and non-renal inflammationDaniela Egli-Spichtig, Pedro Henrique Imenez Silva, Bob Glaudemans, et al.
Lancet (London, England)|June 6, 2021
Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trialBrian G Feagan, Silvio Danese, Edward V Loftus, et al.
Nature Reviews. Gastroenterology & Hepatology|June 3, 2024
A global consensus on the definitions, diagnosis and management of fibrostenosing small bowel Crohn's disease in clinical practiceDominik Bettenworth, Mark E Baker, Joel G Fletcher, et al.
International Journal of Cancer|January 18, 2019
β<sub>6</sub> -integrin serves as a novel serum tumor marker for colorectal carcinomaSusan Bengs, Eugenia Becker, Philipp Busenhart, et al.
Cell Host & Microbe|August 28, 2021
Commensal Clostridiales strains mediate effective anti-cancer immune response against solid tumorsAna Montalban-Arques, Egle Katkeviciute, Philipp Busenhart, et al.
Pageof 55